speb/financial-data huggingface dataset:
HCA income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 930000000.00
HCA income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 226652000.00
HCA income_statement (quarterly, 2026-03-31) — Diluted EPS: 7.15
HCA income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1620000000.00
HCA income_statement (quarterly, 2026-03-31) — EBIT: 2871000000.00
HCA income_statement (quarterly, 2026-03-31) — EBITDA: 3801000000.00
HCA income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 9000000.00
HCA cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -2000000.00
HCA cash_flow (quarterly, 2026-03-31) — End Cash Position: 940000000.00
HCA cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -830000000.00
HCA cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 895000000.00
HCA cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 1000000.00
HCA income_statement (quarterly, 2026-03-31) — Gain On Sale Of Business: -1000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -327000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 10504000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Gross PPE: 69459000000.00
HCA income_statement (quarterly, 2026-03-31) — Gross Profit: 7973000000.00
HCA income_statement (quarterly, 2026-03-31) — Interest Expense: 584000000.00
HCA income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 584000000.00
HCA cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 569000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Inventory: 1681000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Invested Capital: 41720000000.00
HCA cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -1282000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 1002000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Investments In Other Ventures Under Equity Method: 615000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Investmentsin Subsidiariesat Cost: 387000000.00
HCA cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 1435000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 1822000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 39491000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 41313000000.00
HCA cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 1435000000.00
HCA cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -58000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 1002000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Minority Interest: 3325000000.00
HCA income_statement (quarterly, 2026-03-31) — Minority Interests: -237000000.00
HCA cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -262000000.00
HCA cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -1571000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Net Debt: 47083000000.00
HCA income_statement (quarterly, 2026-03-31) — Net Income: 1620000000.00
HCA income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1620000000.00
HCA income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1857000000.00
HCA income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1620000000.00
HCA income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1620000000.00
HCA cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1857000000.00
HCA income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1857000000.00
HCA income_statement (quarterly, 2026-03-31) — Net Interest Income: -584000000.00
HCA cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 103000000.00
HCA cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 1377000000.00
HCA cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 1377000000.00
HCA income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -584000000.00
HCA cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -453000000.00
HCA cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -4000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Net PPE: 33566000000.00
HCA cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1119000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -16807000000.00
HCA income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 3802000000.00
HCA income_statement (quarterly, 2026-03-31) — Normalized Income: 1620812000.00
HCA cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 2014000000.00
HCA cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 1000000.00
HCA income_statement (quarterly, 2026-03-31) — Operating Income: 2863000000.00
HCA income_statement (quarterly, 2026-03-31) — Operating Revenue: 18532000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 222530900.00
HCA balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2107000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -327000000.00
HCA income_statement (quarterly, 2026-03-31) — Other Income Expense: 8000000.00
HCA cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 78000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 326000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 3857000000.00
HCA income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 4180000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Other Properties: 69459000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Payables: 4806000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 10726000000.00
HCA income_statement (quarterly, 2026-03-31) — Pretax Income: 2287000000.00
HCA cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -265000000.00
HCA cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1119000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Receivables: 11324000000.00
HCA income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 11136000000.00
HCA income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 930000000.00
HCA cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -58000000.00
HCA cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -1571000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -5978000000.00
HCA cash_flow (quarterly, 2026-03-31) — Sale Of Business: 3000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Share Issued: 222530900.00
HCA income_statement (quarterly, 2026-03-31) — Special Income Charges: -1000000.00
HCA cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 86000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: -6303000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -16807000000.00
HCA income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -188000.00
HCA income_statement (quarterly, 2026-03-31) — Tax Provision: 430000000.00
HCA income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.19
HCA balance_sheet (quarterly, 2026-03-31) — Total Assets: 61450000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 33188000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Total Debt: 49845000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: -2978000000.00
HCA income_statement (quarterly, 2026-03-31) — Total Expenses: 16246000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 64428000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 45398000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 45170000000.00
HCA income_statement (quarterly, 2026-03-31) — Total Unusual Items: -1000000.00
HCA income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -1000000.00
HCA balance_sheet (quarterly, 2026-03-31) — Working Capital: -3206000000.00
HCAC balance_sheet (quarterly, 2025-07-31) — Capital Stock: 25000.00
HCAC balance_sheet (quarterly, 2025-07-31) — Cash And Cash Equivalents: 4687.00
HCAC balance_sheet (quarterly, 2025-07-31) — Cash Cash Equivalents And Short Term Investments: 4687.00
HCAC balance_sheet (quarterly, 2025-07-31) — Cash Financial: 4687.00
HCAC balance_sheet (quarterly, 2025-07-31) — Common Stock: 25000.00
HCAC balance_sheet (quarterly, 2025-07-31) — Common Stock Equity: 4687.00
HCAC balance_sheet (quarterly, 2025-07-31) — Current Assets: 4687.00
HCAC balance_sheet (quarterly, 2025-07-31) — Invested Capital: 4687.00
HCAC balance_sheet (quarterly, 2025-07-31) — Net Tangible Assets: 4687.00
HCAC balance_sheet (quarterly, 2025-07-31) — Ordinary Shares Number: 25424639.00
HCAC balance_sheet (quarterly, 2025-07-31) — Retained Earnings: -20313.00
HCAC balance_sheet (quarterly, 2025-07-31) — Share Issued: 25424639.00
HCAC balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: 4687.00
HCAC balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: 4687.00
HCAC balance_sheet (quarterly, 2025-07-31) — Total Assets: 4687.00
HCAC balance_sheet (quarterly, 2025-07-31) — Total Capitalization: 4687.00
HCAC balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: 4687.00
HCAC balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 0.00
HCAC balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 0.00
HCAC balance_sheet (annual, 2025-12-31) — Accounts Payable: 54883.00
HCAC balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: -7433994.00
HCAC balance_sheet (annual, 2025-12-31) — Capital Stock: 207000849.00
HCAC balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 631366.00
HCAC balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 631366.00
HCAC balance_sheet (annual, 2025-12-31) — Cash Financial: 631366.00
HCAC balance_sheet (annual, 2025-12-31) — Common Stock: 207000849.00
HCAC balance_sheet (annual, 2025-12-31) — Common Stock Equity: 200219777.00
HCAC balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 4667.00
HCAC balance_sheet (annual, 2025-12-31) — Current Assets: 710677.00
HCAC balance_sheet (annual, 2025-12-31) — Current Liabilities: 59550.00
HCAC balance_sheet (annual, 2025-12-31) — Invested Capital: 200219777.00
HCAC balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 200219777.00
HCAC balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 8280000.00
HCAC balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 62375.00
HCAC balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 29197293.00
HCAC balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 207786276.00
HCAC balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 1.00
HCAC balance_sheet (annual, 2025-12-31) — Payables: 54883.00
HCAC balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 59550.00
HCAC balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
HCAC balance_sheet (annual, 2025-12-31) — Prepaid Assets: 79311.00
HCAC balance_sheet (annual, 2025-12-31) — Retained Earnings: 652922.00
HCAC balance_sheet (annual, 2025-12-31) — Share Issued: 29197293.00
HCAC balance_sheet (annual, 2025-12-31) — Stockholders Equity: 200219777.00
HCAC balance_sheet (annual, 2025-12-31) — Tangible Book Value: 200219777.00
HCAC balance_sheet (annual, 2025-12-31) — Total Assets: 208559328.00
HCAC balance_sheet (annual, 2025-12-31) — Total Capitalization: 200219777.00
HCAC balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 200219777.00
HCAC balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 8339551.00
HCAC balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 207848651.00
HCAC balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 8280001.00
HCAC balance_sheet (annual, 2025-12-31) — Working Capital: 651127.00
HCAC income_statement (quarterly, 2026-03-31) — +Operating Expense: 183126.00
HCAC income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
HCAC balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 40000.00
HCAC balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: -7433994.00
HCAC income_statement (quarterly, 2026-03-31) — Basic Average Shares: 29197293.00
HCAC income_statement (quarterly, 2026-03-31) — Basic EPS: 0.08
HCAC cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 631366.00
HCAC balance_sheet (quarterly, 2026-03-31) — Capital Stock: 207000849.00
HCAC balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 463036.00
HCAC balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 463036.00
HCAC balance_sheet (quarterly, 2026-03-31) — Cash Financial: 463036.00
HCAC cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 4687.00
HCAC cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 200.00
HCAC cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -173218.00
HCAC cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 34520.00
HCAC cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -24812.00
HCAC cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 9708.00
HCAC cash_flow (quarterly, 2026-03-31) — Changes In Cash: -168330.00
HCAC balance_sheet (quarterly, 2026-03-31) — Common Stock: 207000849.00
HCAC balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 201876723.00
HCAC cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
HCAC balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 4667.00
HCAC balance_sheet (quarterly, 2026-03-31) — Current Assets: 534890.00
HCAC balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 44667.00
HCAC income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 29197293.00
HCAC income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.08
HCAC income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1652279.00
HCAC income_statement (quarterly, 2026-03-31) — EBIT: -183126.00
HCAC income_statement (quarterly, 2026-03-31) — EBITDA: -183126.00
HCAC cash_flow (quarterly, 2026-03-31) — End Cash Position: 463036.00
HCAC cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 4687.00
HCAC cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -173218.00
HCAC income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 183126.00
HCAC income_statement (quarterly, 2026-03-31) — Gross Profit: 0.00
HCAC income_statement (quarterly, 2026-03-31) — Interest Income: 1835406.00
HCAC income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 1835406.00
HCAC cash_flow (quarterly, 2026-03-31) — Interest Received Cfi: 200.00
HCAC balance_sheet (quarterly, 2026-03-31) — Invested Capital: 201876723.00
HCAC cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 200.00
HCAC cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
HCAC cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 0.00
HCAC cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
HCAC cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 0.00
HCAC cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
HCAC income_statement (quarterly, 2026-03-31) — Net Income: 1652279.00
HCAC income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1652279.00
HCAC income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 1652280.00
HCAC income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 1652279.00
HCAC income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 1652279.00
HCAC cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 1652279.00
HCAC income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 1652280.00
HCAC income_statement (quarterly, 2026-03-31) — Net Interest Income: 1835406.00
HCAC cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
HCAC cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
HCAC income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 1835406.00
HCAC cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 4687.00
HCAC balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 201876723.00
HCAC balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 8280000.00
HCAC balance_sheet (quarterly, 2026-03-31) — Non Current Prepaid Assets: 45020.00
HCAC income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -183126.00
HCAC income_statement (quarterly, 2026-03-31) — Normalized Income: 1652279.00
HCAC cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -173218.00
HCAC income_statement (quarterly, 2026-03-31) — Operating Income: -183126.00
HCAC income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
HCAC balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 29197293.00
HCAC income_statement (quarterly, 2026-03-31) — Other Gand A: 183126.00
HCAC cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -1835205.00
HCAC balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 209621481.00
HCAC balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1.00
HCAC balance_sheet (quarterly, 2026-03-31) — Payables: 40000.00
HCAC balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 44667.00
HCAC balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
HCAC balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 71854.00
HCAC income_statement (quarterly, 2026-03-31) — Pretax Income: 1652280.00
HCAC cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 0.00
HCAC balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 2309868.00
HCAC income_statement (quarterly, 2026-03-31) — Selling General And Administration: 183126.00
HCAC balance_sheet (quarterly, 2026-03-31) — Share Issued: 29197293.00
HCAC balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 201876723.00
HCAC balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 201876723.00
HCAC income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
HCAC income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
HCAC balance_sheet (quarterly, 2026-03-31) — Total Assets: 210201391.00
HCAC balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 201876723.00
HCAC balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 201876723.00
HCAC income_statement (quarterly, 2026-03-31) — Total Expenses: 183126.00
HCAC balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 8324668.00
HCAC balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 209666501.00
HCAC balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 8280001.00
HCAC balance_sheet (quarterly, 2026-03-31) — Working Capital: 490223.00
HCAI balance_sheet (annual, 2021-12-31) — Accumulated Depreciation: -808547.00
HCAI balance_sheet (annual, 2021-12-31) — Allowance For Doubtful Accounts Receivable: -519530.00
HCAI cash_flow (annual, 2021-12-31) — Amortization Cash Flow: 227421.00
HCAI cash_flow (annual, 2021-12-31) — Amortization Of Intangibles: 227421.00
HCAI income_statement (annual, 2021-12-31) — Basic Average Shares: 999999.00
HCAI income_statement (annual, 2021-12-31) — Basic EPS: -0.84
HCAI cash_flow (annual, 2021-12-31) — Capital Expenditure: -2973997.00
HCAI cash_flow (annual, 2021-12-31) — Change In Inventory: -725745.00
HCAI cash_flow (annual, 2021-12-31) — Change In Other Current Liabilities: -177538.00
HCAI cash_flow (annual, 2021-12-31) — Change In Other Working Capital: 1540961.00
HCAI balance_sheet (annual, 2021-12-31) — Construction In Progress: 8973545.00
HCAI balance_sheet (annual, 2021-12-31) — Current Debt: 5178421.00
HCAI balance_sheet (annual, 2021-12-31) — Current Notes Payable: 0.00
HCAI income_statement (annual, 2021-12-31) — Diluted Average Shares: 1049999.00
HCAI income_statement (annual, 2021-12-31) — Diluted EPS: -0.84
HCAI balance_sheet (annual, 2021-12-31) — Duefrom Related Parties Current: 987210.00
HCAI balance_sheet (annual, 2021-12-31) — Dueto Related Parties Current: 616261.00
HCAI balance_sheet (annual, 2021-12-31) — Finished Goods: 10212885.00
HCAI balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 2556133.00
HCAI balance_sheet (annual, 2021-12-31) — Gross Accounts Receivable: 6019136.00
HCAI income_statement (annual, 2021-12-31) — Interest Expense: 817375.00
HCAI income_statement (annual, 2021-12-31) — Interest Expense Non Operating: 817375.00
HCAI balance_sheet (annual, 2021-12-31) — Inventory: 11269324.00
HCAI balance_sheet (annual, 2021-12-31) — Line Of Credit: 5178421.00
HCAI balance_sheet (annual, 2021-12-31) — Long Term Debt: 5492264.00
HCAI balance_sheet (annual, 2021-12-31) — Machinery Furniture Equipment: 705718.00
HCAI balance_sheet (annual, 2021-12-31) — Net Debt: 10092049.00
HCAI cash_flow (annual, 2021-12-31) — Net PPE Purchase And Sale: -2973997.00
HCAI balance_sheet (annual, 2021-12-31) — Non Current Deferred Assets: 214643.00
HCAI balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 214643.00
HCAI balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 5178421.00
HCAI balance_sheet (annual, 2021-12-31) — Other Current Liabilities: 12061939.00
HCAI balance_sheet (annual, 2021-12-31) — Other Intangible Assets: 2556133.00
HCAI balance_sheet (annual, 2021-12-31) — Other Properties: 1744805.00
HCAI cash_flow (annual, 2021-12-31) — Provisionand Write Offof Assets: 304210.00
HCAI cash_flow (annual, 2021-12-31) — Purchase Of PPE: -2973997.00
HCAI balance_sheet (annual, 2021-12-31) — Raw Materials: 933657.00
HCAI balance_sheet (annual, 2021-12-31) — Receivables Adjustments Allowances: -10229.00
HCAI cash_flow (annual, 2021-12-31) — Repayment Of Debt: -1937740.00
HCAI balance_sheet (annual, 2021-12-31) — Restricted Cash: 0.00
HCAI income_statement (annual, 2021-12-31) — Selling And Marketing Expense: 284297.00
HCAI cash_flow (annual, 2021-12-31) — Short Term Debt Payments: -1937740.00
HCAI balance_sheet (annual, 2021-12-31) — Taxes Receivable: 1691670.00
HCAI balance_sheet (annual, 2021-12-31) — Tradeand Other Payables Non Current: 1289884.00
HCAI balance_sheet (annual, 2021-12-31) — Work In Process: 122782.00
HCAI income_statement (annual, 2022-12-31) — +Operating Expense: 2203701.00
HCAI income_statement (annual, 2022-12-31) — +Total Revenue: 20955188.00
HCAI balance_sheet (annual, 2022-12-31) — Accounts Payable: 3014894.00
HCAI balance_sheet (annual, 2022-12-31) — Accounts Receivable: 12468579.00
HCAI balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -957666.00
HCAI balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 3462427.00
HCAI balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -903462.00
HCAI cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 229102.00
HCAI cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 229102.00
HCAI income_statement (annual, 2022-12-31) — Basic Average Shares: 999999.00
HCAI income_statement (annual, 2022-12-31) — Basic EPS: 4.20
HCAI cash_flow (annual, 2022-12-31) — Beginning Cash Position: 578636.00
HCAI balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 0.00
HCAI cash_flow (annual, 2022-12-31) — Capital Expenditure: -440657.00
HCAI balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 16031.00
HCAI balance_sheet (annual, 2022-12-31) — Capital Stock: 38.00
HCAI balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 605734.00
HCAI balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 605734.00
HCAI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 2934432.00
HCAI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -440657.00
HCAI cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -860839.00
HCAI cash_flow (annual, 2022-12-31) — Change In Account Payable: -42904.00
HCAI cash_flow (annual, 2022-12-31) — Change In Accrued Expense: -5221628.00
HCAI cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 1968666.00
HCAI cash_flow (annual, 2022-12-31) — Change In Inventory: 6062566.00
HCAI cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -189934.00
HCAI cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -9497494.00
HCAI cash_flow (annual, 2022-12-31) — Change In Payable: 1925762.00
HCAI cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: -3295866.00
HCAI cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: 5611790.00
HCAI cash_flow (annual, 2022-12-31) — Change In Receivables: -5939637.00
HCAI cash_flow (annual, 2022-12-31) — Change In Tax Payable: 1968666.00
HCAI cash_flow (annual, 2022-12-31) — Change In Working Capital: -7248575.00